Aims and Scope: The Journal of Angiotherapy is an, international, peer-reviewed, Open Access journal that publishes research articles on all aspects of angiogenesis in a continuous publication schedule. Multi-disciplinary, fully peer-reviewed, international scholarly journal. It will publish the article 1) describe significant and novel findings; and 2) advance knowledge in a diversity of scientific fields in angiogenesis and its related research areas. Angiogenesis, the process of new blood vessel formation, plays a pivotal role in various physiological and pathological conditions, including wound healing, cancer, cardiovascular diseases, and more.
We invite researchers, scientists, and experts in the field to contribute their latest findings and insights to our upcoming special issue. Submissions may cover a wide range of topics related to angiogenesis, including but not limited to: Cancer, Cancer biomarkers, vascular disease, cardiovascular, endothelial cell biology, ocular disease, microvascular, neovascular disease, inflammation, neurodegenrative diseases, autoimmune disease and natural agents and therapeutics.
The Journal also welcomes submission of manuscripts from cross-disciplinary fields, including Pharmaceutical Sciences, Biochemistry & Structural Biology, Biotechnology, Bioinformatics & Computational Biology, Cell, Molecular & Developmental Biology, Medicine, Evolutionary Biology & Molecular Ecology, Genetics & Genomics, Immunology, Microbiology, Parasitology & Virology, Neuroscience, Plant Sciences, Chemical Sciences, and Zoology.
Peer-Review Process: The journal is committed to publishing research works by utilizing a rapid, impartial, and rigorous review process. All submitted papers are subjected to strict single-blind peer review by its distinguished international Advisory Board members, as well as by other anonymous international and national reviewers. Submitted manuscripts must not have been published previously in any copyright form (print or electronic/online).
The journal is committed to publishing research works by utilizing a rapid, impartial, and rigorous review process. All submitted papers are subjected to strict single blind peer review by its distinguished international Advisory Board members, as well as by other anonymous international and national reviewers. Submitted manuscripts must not have been published previously in any copyright form (print or electronic/online).
The general criteria for acceptance of a manuscript are:
advances Angiogenesis and herbal therapeutics based scientific knowledge;
advances translational research;
provides an adequate and relevant literature review;
utilizes scientifically solid, reliable, and reproducible methodologies;
derives appropriate and justifiable conclusions based upon the experimental data presented; and
is written in English and is of the utmost quality and clarity.
Angiotherapy is dedicated to the dissemination of fundamental information related to the clinical and pre-clinical research on natural products, plant extract, small molecules in angiogenesis and angiogenesis dependent disease including cancer, arthritis and obesity. Full-length articles presenting the results of original research, Review, Data report and brief communications are featured. The Journal publish article continuously. All accepted manuscripts are granted free online open-access immediately after publication, which permits its users to read, download, copy, distribute, print, search, or link to the full texts of its articles, thus facilitating access to a broad readership.
Angiotherapy facilitates the author's response to the NIH Public Access Policy. For more details please see the Guide for authors.
Research Angiogenesis-related areas include:
- Comparative physiology
- Drug delivery